EUVIMEDEUVIMED entdecken
Crossref

Blockade of OSMRβ signaling ameliorates skin lesions in a mouse model of human atopic dermatitis

Tadasuke Komori iD, Tomoko Hisaoka iD, Ayumi Kotaki iD, Miki Iwamoto iD, Atsushi Miyajima iD, Eiji Esashi iD, Yoshihiro Morikawa iD

The FASEB Journal · 15.01.2024 · 38 (1)

DOI: 10.1096/fj.202301529r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 16.12.2023. Verfasst von Tadasuke Komori und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy & Neurobiology, Wakayama Medical University, Wakayama, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Accelerating Utilization of University IP Program, GSK | GlaxoSmithKline Japan (GSK), MEXT | JST | Adaptable and Seamless Technology Transfer Program through Target-Driven R and D (A-STEP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by severe pruritus and eczematous skin lesions. Although IL‐31, a type 2 helper T (Th2)‐derived cytokine, is important to the development of pruritus and skin lesions in AD, the blockade of IL‐31 signaling does not improve the skin lesions in AD. Oncostatin M (OSM), a member of IL‐6 family of cytokines, plays important roles in the regulation of various inflammatory responses through OSM receptor β subunit (OSMRβ), a common receptor subunit for OSM and IL‐31. However, the effects of OSM on the pathogenesis of AD remain to be elucidated. When AD model mice were treated with OSM, skin lesions were exacerbated and IL‐4 production was increased in the lymph nodes. Next, we investigated the effects of the monoclonal antibody (mAb) against OSMRβ on the pathogenesis of AD. Treatment with the anti‐OSMRβ mAb (7D2) reduced skin severity score in AD model mice. In addition to skin lesions, scratching behavior was decreased by 7D2 mAb with the reduction in the number of OSMRβ‐positive neurons in the dorsal root ganglia of AD model mice. 7D2 mAb also reduced the serum concentration of IL‐4, IL‐13, and IgE as well as the gene expressions of IL‐4 and IL‐13 in the lymph nodes of AD model mice. Blockade of both IL‐31 and OSM signaling is suggested to suppress both pruritus and Th2 responses, resulting in the improvement of skin lesions in AD. The anti‐OSMRβ mAb may be a new therapeutic candidate for the treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansMiceAnimalsInterleukin-13Interleukin-4SkinCytokinesPruritus

Stichwörter der Autor:innen

atopic dermatitiscytokinesinflammationoncostatin Moncostatin M receptor beta subunitpruritus

Substanzen

Interleukin-13Interleukin-4Cytokines

Autor:innen und Institutionen

  • Department of Anatomy & Neurobiology, Wakayama Medical University, Wakayama, Japan.
  • Ginkgo Biomedical Research Institute, R&D Department, SBI Biotech Co. Ltd, Fujisawa, Japan.
  • Department of Pediatrics, Kainan Municipal Medical Center, Kainan, Japan.
  • Laboratory of Cell Growth and Differentiation, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Tadasuke Komori, Tomoko Hisaoka, Ayumi Kotaki, Miki Iwamoto, Atsushi Miyajima, Eiji Esashi, Yoshihiro Morikawa

Förderung

  • Accelerating Utilization of University IP Program
  • GSK | GlaxoSmithKline Japan (GSK)
  • MEXT | JST | Adaptable and Seamless Technology Transfer Program through Target-Driven R and D (A-STEP)

Zitieren

APA

Komori, T., Hisaoka, T., Kotaki, A., Iwamoto, M., Miyajima, A., Esashi, E., & Morikawa, Y. (2024). Blockade of OSMRβ signaling ameliorates skin lesions in a mouse model of human atopic dermatitis. The FASEB Journal, 38(1). https://doi.org/10.1096/fj.202301529r

Vancouver

Komori T, Hisaoka T, Kotaki A, Iwamoto M, Miyajima A, Esashi E, et al. Blockade of OSMRβ signaling ameliorates skin lesions in a mouse model of human atopic dermatitis. The FASEB Journal. 2024;38(1). doi:10.1096/fj.202301529r

BibTeX
@article{Komori2024,
  author = {Komori, Tadasuke and Hisaoka, Tomoko and Kotaki, Ayumi and Iwamoto, Miki and Miyajima, Atsushi and Esashi, Eiji and Morikawa, Yoshihiro},
  title = {Blockade of OSMRβ signaling ameliorates skin lesions in a mouse model of human atopic dermatitis},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {1},
  doi = {10.1096/fj.202301529r}
}
Kostenlos starten →